EXAMINATION OF THE 3 MOLECULAR FORMS OF SERUM PROSTATE SPECIFIC ANTIGEN FOR DISTINGUISHING NEGATIVE FROM POSITIVE BIOPSY: RELATIONSHIP TO TRANSITION ZONE VOLUME
- 1 January 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (1), 119-126
- https://doi.org/10.1016/s0022-5347(05)67986-4
Abstract
Purpose: We evaluated the relative usefulness of total, free and complexed serum prostate specific antigen (PSA), and their ratios for distinguishing positive from negative biopsy of prostates in a university referral practice. Materials and Methods: We compared 90 consecutive men who had 2 sets of 6 negative systematic biopsies with 70 who had at least 5 mm. of prostate cancer in systematic biopsies during the same period at our institution. Total prostate and transition zone volumes were determined by transrectal ultrasound. The Bayer, † Bayer, Tarrytown, New York. DPC ‡ DPC, Los Angeles, California. ‡ and Hybritech § Hybritech, Inc., San Diego, California. assays were performed to measure total, free and complexed serum PSA. Receiver operating characteristics curves were constructed for all forms of serum PSA and their ratios as well as prostate size to distinguish true positive (sensitivity) from false-positive (1 minus specificity) fractions. Results: Complexed PSA was only marginally better than total serum PSA. Free-to-total, complexed-to-total and prostate size had highly significant areas under the curves of greater than 80%. Free PSA only was better than complexed or total PSA. When factored by prostate volume, total PSA performed as well as the PSA ratios, and transition zone volume was consistently better than total prostate volume. DPC free-to-total ratios were equivalent to Hybritech ratios in all respects. Conclusions: Complexed PSA is only marginally better than total PSA for distinguishing negative from positive biopsy of prostates. It is inferior to free PSA and far less useful than free-to-total or complexed-to-total ratios. Prostate size is a decisive variable in men in whom we avoided the expected 25% false-negative biopsy rate in terms of specificity and hopefully avoided insignificant cancer in terms of sensitivity. In the future the performance of PSA serum markers should be related to a transition zone volume of less than 20, 20 to 60 and greater than 60 gm. when comparing assays to each other.Keywords
This publication has 26 references indexed in Scilit:
- PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR EARLY DETECTION OF PROSTATE CANCERJournal of Urology, 1998
- A MODEL FOR THE NUMBER OF CORES PER PROSTATE BIOPSY BASED ON PATIENT AGE AND PROSTATE GLAND VOLUMEJournal of Urology, 1998
- ONE CORE POSITIVE PROSTATE BIOPSY IS A POOR PREDICTOR OF CANCER VOLUME IN THE RADICAL PROSTATECTOMY SPECIMENJournal of Urology, 1997
- Prevalence and Predictors of a Positive Repeat Transrectal Ultrasound Guided Needle Biopsy of the ProstateJournal of Urology, 1997
- Can Free and Total Prostate Specific Antigen and Prostatic Volume Distinguish Between Men With Negative and Positive Systematic Ultrasound Guided Prostate Biopsies?Journal of Urology, 1997
- A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenarioJournal of Urology, 1996
- Limitations of Serum Prostate Specific Antigen in Predicting Peripheral and Transition Zone Cancer Volumes as Measured by Correlation CoefficientsJournal of Urology, 1996
- Prostatic Transition Zone Biopsies in Men with Previous Negative Biopsies and Persistently Elevated Serum Prostate Specific Antigen ValuesJournal of Urology, 1995
- Correlation Between Serum Prostate Specific Antigen Levels and the Volume of the Individual Glandular Zones of the Human ProstateJournal of Urology, 1995
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978